Zydus Lifesciences Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ZYDUS LIFESCIENCES, and what generic alternatives to ZYDUS LIFESCIENCES drugs are available?
ZYDUS LIFESCIENCES has seventy-one approved drugs.
There is one US patent protecting ZYDUS LIFESCIENCES drugs. There is one tentative approval on ZYDUS LIFESCIENCES drugs.
There are four patent family members on ZYDUS LIFESCIENCES drugs in four countries and one hundred and eighty-eight supplementary protection certificates in sixteen countries.
Summary for Zydus Lifesciences
| International Patents: | 4 |
| US Patents: | 1 |
| Tradenames: | 61 |
| Ingredients: | 61 |
| NDAs: | 71 |
Drugs and US Patents for Zydus Lifesciences
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Zydus Lifesciences | CYCLOPHOSPHAMIDE | cyclophosphamide | CAPSULE;ORAL | 211552-001 | Dec 13, 2023 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Zydus Lifesciences | NORTRIPTYLINE HYDROCHLORIDE | nortriptyline hydrochloride | CAPSULE;ORAL | 213441-004 | Feb 24, 2021 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Zydus Lifesciences | BACLOFEN | baclofen | TABLET;ORAL | 211659-003 | Apr 17, 2020 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Zydus Lifesciences | ACETAZOLAMIDE | acetazolamide | TABLET;ORAL | 211069-001 | Apr 4, 2023 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Zydus Lifesciences | FLUOCINONIDE | fluocinonide | CREAM;TOPICAL | 208989-001 | Feb 10, 2020 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Zydus Lifesciences | DOXEPIN HYDROCHLORIDE | doxepin hydrochloride | CAPSULE;ORAL | 210700-005 | Mar 23, 2023 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Zydus Lifesciences Drugs
Supplementary Protection Certificates for Zydus Lifesciences Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 1412357 | 91360 | Luxembourg | ⤷ Sign Up | PRODUCT NAME: SITAGLIPTIN; AUTHORISATION NUMBER AND DATE: EU/1/07/383/001-018 20070323 |
| 0281459 | 9890035-0 98910359 | Sweden | ⤷ Sign Up | PRODUCT NAME: PLAVIX-CLOPIDOGREL; REG. NO/DATE: EU/1/98/069/001 19980715 |
| 1020454 | SPC/GB10/019 | United Kingdom | ⤷ Sign Up | SUPPLEMENTARY PROTECTION CERTIFICATE NO SPC/GB10/019 GRANTED TO TEIJIN LIMITED IN RESPECT OF THE PRODUCT FEBUXOSTAT, THE GRANT OF WHICH WAS ADVERTISED IN JOURNAL NO 6408 DATED 14/03/2012 HAS HAD ITS MAXIMUM PERIOD OF DURATION CORRECTED, SUBJECT TO THE PAYMENT OF THE PRESCRIBED FEES IT WILL EXPIRE ON 22/04/2023. |
| 0809498 | 10C0038 | France | ⤷ Sign Up | PRODUCT NAME: ACYCLOVIR ET HYDROCORTISONE; NAT. REGISTRATION NO/DATE: NL 36 826 20100420; FIRST REGISTRATION: SK - 2108/08467-R 20091026 |
| 2498758 | PA2020003 | Lithuania | ⤷ Sign Up | PRODUCT NAME: METFORMINAS ARBA FARMACINIU POZIURIU PRIIMTINA JO DRUSKA; SAKSAGLIPTINAS ARBA FARMACINIU POZIURIU PRIIMTINA JO DRUSKA; DAPAGLIFLOZINAS ARBA FARMACINIU POZIURIU PRIIMTINAS JO SOLVATAS; REGISTRATION NO/DATE: EU/1/19/1401 20191111 |
| 1261586 | 132012902044560 | Italy | ⤷ Sign Up | PRODUCT NAME: SAXAGLIPTIN E METFORMINA(KOMBOGLYZE); AUTHORISATION NUMBER(S) AND DATE(S): DA EU/1/11/731/001 A EU/1/11/731/014, 20111124 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
